Activity record

PGDB_A005444

Assay: biochemicalTarget: CRBNQC: standardized
Activity overview

inhibition = 40-53 %

TargetCRBN
E3 ligaseCRBN
Concentration0.5 uM
Assay / ReadoutHTRF / % Inhibition
Assay IDPGDB_AS000662
PatentWO2026061475A1
QC statusstandardized
Evidence details

Compound, assay context, and source

Compound

2D structure for PGDB_C030556
Compound IDPGDB_C030556
CompoundGT-11106
Source record IDPGDB_C030556
InChIKeyJJIBLFCTBANMHC-UHFFFAOYSA-N

Assay context

Assay IDPGDB_AS000662
Assay familybiochemical
Assay systemcell_based
Readout% Inhibition
TechnologyHTRF
Concentration0.5 uM
Detection targetcell_inhibition
TargetCRBN
E3CRBN
OrganismHomo sapiens

Source evidence

Patent IDWO2026061475A1
Compound location

GT-11106

GT-11106 enlarged structureGT-11106 location on patent page 89
Activity table
Page 215 · table start
Page 216 · table end